Impact of Clinical Pharmacy Services on KAP and QOL in Cancer Patients: A Single-Center Experience

Table 1

Comparison of patients’ demographic and clinical characteristics.

Characteristic	Control group ()	Intervention group ()
Sex			0.018	0.892
Male	41 (56.9)	43 (55.8)
Female	31 (43.1)	34 (44.2)
Age, years			1.087	0.297
≤50	35 (48.6)	44 (57.1)
>50	37 (51.4)	33 (42.9)
Marital status			1.577	0.209
Single	9 (12.5)	5 (6.5)
Married	63 (87.5)	72 (93.5)
Education level			0.671	0.715
Low	41 (56.9)	48 (62.3)
Middle	27 (37.5)	24 (31.2)
High	4 (5.6)	5 (6.5)
Medical expense			2.366	0.500
Own expense	8 (11.1)	5 (6.5)
Rural medical cooperation	19 (26.4)	24 (31.2)
Medical insurance	38 (52.8)	44 (57.1)
Public-funded	7 (9.7)	4 (5.2)
Chemotherapy cycles			0.677	0.713
0	43 (59.7)	49 (63.6)
1	16 (22.2)	13 (16.9)
2	13 (18.1)	15 (19.5)
Tumor staging			3.177	0.529
Unknowns	0 (0)	2 (2.6)
I	7 (9.7)	5 (6.5)
II	12 (6.7)	9 (11.7)
III	18 (25.0)	20 (26.0)
IV	35 (48.6)	41 (53.2)

Data presented as (%) patients.
Between-groups comparison (control versus intervention group, before study), Chi-squared test.